Jeremy Grantham Bausch Health Companies Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $1.53 Million - $2.11 Million	-99,700 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $1.8 Million - $2.43 Million	-120,900 Reduced 54.81%	99,700 $1.55 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $1.44 Million - $2.22 Million	-108,400 Reduced 32.95%	220,600 $4.02 Million
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $12,980 - $30,250	-1,000 Reduced 0.3%	329,000 $5.04 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $6.23 Million - $10.5 Million	330,000 New	330,000 $9.89 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.03B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.